Health and Fitness Health and Fitness
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008
Mon, December 22, 2008
Sun, December 21, 2008
Fri, December 19, 2008
Thu, December 18, 2008

ZymoGenetics to Webcast Presentation at J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. ntation-at-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Tuesday, January 6th 2009 at 3:30 GMT, Last Modified on 2009-01-06 03:31:00 by Market Wire   Print publication without navigation


SEATTLE--([ BUSINESS WIRE ])--ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, will provide an update on company activities at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2009 at 3:30 p.m. Pacific Time.

A live webcast of the presentation can be accessed by going to: [ www.zymogenetics.com ]. The webcast will be archived for 30 days.

About ZymoGenetics

ZymoGenetics discovers and develops novel protein therapeutics that are based on the company's research and biological insights into key disease pathways. The Company developed and markets RECOTHROM® Thrombin, topical (Recombinant). Other product candidates span a wide array of clinical opportunities that include cancer, autoimmune and viral diseases. ZymoGenetics intends to commercialize product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio. For further information, visit [ www.zymogenetics.com ].

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current intent and expectations of the management of ZymoGenetics.These statements are not guarantees of future actions and involve uncertainties that are difficult to predict. Except as required by law, ZymoGenetics undertakes no obligation to update any forward-looking or other statements in this press release, whether as a result of new information, future events or otherwise.


Publication Contributing Sources

Similar Health and Fitness Publications